Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Viatris Inc.

Capitalization 16.21B 13.92B 12.58B 12.05B 22.01B 1,489B 22.7B 148B 59.35B 714B 60.84B 59.55B 2,556B P/E ratio 2026 *
47.9x
P/E ratio 2027 * 22x
Enterprise value 28.22B 24.23B 21.91B 20.97B 38.31B 2,592B 39.51B 258B 103B 1,243B 106B 104B 4,449B EV / Sales 2026 *
1.93x
EV / Sales 2027 * 1.8x
Free-Float
96.32%
Yield 2026 *
3.61%
Yield 2027 * 3.71%
1 day-0.98%
1 week-5.44%
Current month-5.69%
1 month-11.72%
3 months+21.38%
6 months+37.50%
Current year+13.09%
1 week 13.8
Extreme 13.795
14.72
1 month 13.8
Extreme 13.795
16.47
Current year 12.19
Extreme 12.19
16.47
1 year 6.85
Extreme 6.85
16.47
3 years 6.85
Extreme 6.85
16.47
5 years 6.85
Extreme 6.85
16.47
10 years 6.85
Extreme 6.85
50.4
Manager TitleAgeSince
Chief Executive Officer 63 31/03/2023
Director of Finance/CFO 43 31/12/2023
Chief Tech/Sci/R&D Officer - 14/12/2023
Director TitleAgeSince
Director/Board Member 78 15/11/2020
Director/Board Member 78 15/11/2020
Director/Board Member 62 15/11/2020
Change 5d. change 1-year change 3-years change Capi.($)
-0.98%-5.44%+48.21%+40.80% 16.21B
-0.70%-0.63%+20.68%+217.87% 895B
+0.46%-1.23%+45.32%+60.75% 587B
-0.19%-2.93%+4.78%+51.63% 401B
+0.84%-5.68%+9.04%+27.14% 345B
-2.63%-3.48%+20.34%+63.50% 300B
+1.47%-1.86%+23.75%+36.98% 306B
-0.02%-2.29%+22.95%+8.73% 289B
-0.41%-0.42%+14.68%+64.76% 202B
+1.32%+0.49%+26.75%+86.87% 184B
Average -0.08%-2.35%+23.65%+65.90% 352.67B
Weighted average by Cap. -0.10%-1.92%+22.36%+91.68%

Financials

2026 *2027 *
Net sales 14.61B 12.54B 11.34B 10.85B 19.83B 1,341B 20.45B 134B 53.47B 643B 54.82B 53.65B 2,303B 14.86B 12.76B 11.53B 11.04B 20.16B 1,364B 20.8B 136B 54.38B 654B 55.75B 54.57B 2,342B
Net income 184M 158M 143M 137M 250M 16.94B 258M 1.69B 675M 8.12B 692M 678M 29.08B 594M 510M 461M 442M 807M 54.59B 832M 5.43B 2.18B 26.17B 2.23B 2.18B 93.71B
Net Debt 12.01B 10.31B 9.32B 8.93B 16.3B 1,103B 16.82B 110B 43.96B 529B 45.07B 44.11B 1,893B 10.52B 9.03B 8.16B 7.82B 14.27B 966B 14.72B 96.14B 38.5B 463B 39.47B 38.63B 1,658B
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The Company operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.
Employees
30,000
Date Price Change Volume
10/03/26 14.08 $ -0.98% 8,863,929
09/03/26 14.22 $ +0.42% 8,863,382
06/03/26 14.16 $ -2.55% 10,821,281
05/03/26 14.53 $ -1.22% 9,547,944
04/03/26 14.71 $ -1.21% 12,586,916
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
14.08USD
Average target price
15.50USD
Spread / Average Target
+10.09%

Quarterly revenue - Rate of surprise

SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW